PRODUCT DETAIL

Lipocomb 20 mg/10 mg

Code

1287B

MA number

31/0290/14-S

Product Form:

cps dur 10x20 mg/10 mg (blis.OPA/Al/PVC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

Egis Pharmaceuticals PLC, Hungary

Therapeutic Class:

31 - HYPOLIPIDAEMICA

ATC:

C	CARDIOVASCULAR SYSTEM
C10	Lipid modifying agents
C10B	Lipid modifying agents, combinations
C10BA	Combinations of various lipid modifying agents
C10BA06	Rosuvastatin and ezetimibe

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10b fixed combination application
MA issued:	04.09.2014
Pediatric warnings:	Yes
PIL:	PIL_Lipocomb 10 mg-10 mg, 20 mg-10 mg_12.2023.pdf
SPC:	SPC_Lipocomb 10 mg-10 mg, 20 mg-10 mg_12.2023.pdf
Safety feature	Yes
Data update:	23.04.2020